KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334,841 | -62.0% | 36,715 | -55.9% | 0.01% | -65.2% |
| Q2 2023 | $881,557 | +20.3% | 83,323 | +55.3% | 0.02% | -11.5% |
| Q3 2022 | $733,000 | +102.5% | 53,641 | +171.3% | 0.03% | +62.5% |
| Q2 2022 | $362,000 | +87.6% | 19,775 | +43.6% | 0.02% | +33.3% |
| Q4 2021 | $193,000 | -19.2% | 13,768 | +7.9% | 0.01% | -36.8% |
| Q3 2021 | $239,000 | -52.4% | 12,760 | -47.0% | 0.02% | -54.8% |
| Q2 2021 | $502,000 | +129.2% | 24,056 | +210.0% | 0.04% | +110.0% |
| Q1 2021 | $219,000 | -70.0% | 7,760 | -65.3% | 0.02% | -74.0% |
| Q4 2020 | $731,000 | +163.9% | 22,375 | +31.6% | 0.08% | +305.3% |
| Q2 2020 | $277,000 | -10.4% | 17,001 | -45.3% | 0.02% | -13.6% |
| Q1 2020 | $309,000 | +82.8% | 31,086 | +153.5% | 0.02% | +120.0% |
| Q4 2019 | $169,000 | -22.1% | 12,261 | -1.1% | 0.01% | -37.5% |
| Q3 2018 | $217,000 | – | 12,396 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |